Literature DB >> 15944607

Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.

Toru Ogata1, Hidenori Shibamura, Gerard Tromp, Moumita Sinha, Katrina A B Goddard, Natzi Sakalihasan, Raymond Limet, Gerald L MacKean, Claudette Arthur, Taijiro Sueda, Susan Land, Helena Kuivaniemi.   

Abstract

BACKGROUND: Abdominal aortic aneurysms (AAAs) are characterized by histologic signs of chronic inflammation, destructive remodeling of extracellular matrix, and depletion of vascular smooth muscle cells. We investigated the process of extracellular matrix remodeling by performing a genetic association study with polymorphisms in the genes for matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and structural extracellular matrix molecules in AAA. Our hypothesis was that genetic variations in one or more of these genes contribute to greater or lesser activity of these gene products, and thereby contribute to susceptibility for developing AAAs.
METHODS: DNA samples from 812 unrelated white subject (AAA, n = 387; controls, n = 425) were genotyped for 14 polymorphisms in 13 different candidate genes: MMP1(nt-1607), MMP2(nt-955), MMP3(nt-1612), MMP9(nt-1562), MMP10(nt+180), MMP12(nt-82), MMP13(nt-77), TIMP1(nt+434), TIMP1(rs2070584), TIMP2(rs2009196), TIMP3(nt-1296), TGFB1(nt-509), ELN(nt+422), and COL3A1(nt+581). Odds ratios and P values adjusted for gender and country of origin using logistic regression and stratified by family history of AAA were calculated to test for association between genotype and disease status. Haplotype analysis was carried out for the two TIMP1 polymorphisms in male subjects.
RESULTS: Analyses with one polymorphism per test without interactions showed an association with the two TIMP1 gene polymorphisms (nt+434, P = .0047; rs2070584, P = .015) in male subjects without a family history of AAA. The association remained significant when analyzing TIMP1 haplotypes (chi 2 P = .014 and empirical P = .009). In addition, we found a significant interaction between the polymorphism and gender for MMP10 ( P = .037) in cases without a family history of AAA, as well as between the polymorphism and country of origin for ELN ( P = .0169) and TIMP3 ( P = .0023) in cases with a family history of AAA.
CONCLUSIONS: These findings suggest that genetic variations in TIMP1, TIMP3, MMP10, and ELN genes may contribute to the pathogenesis of AAAs. Further work is needed to confirm the findings in an independent set of samples and to study the functional role of these variants in AAA. It is noteworthy that contrary to a previous study, we did not find an association between the MMP9 (nt-1562) polymorphism and AAA, suggesting genetic heterogeneity of the disease. CLINICAL RELEVANCE: Abdominal aortic aneurysms (AAAs) are an important cardiovascular disease, but the genetic and environmental risk factors, which contribute to individual's risk to develop an aneurysm, are poorly understood. Histologically, AAAs are characterized by signs of chronic inflammation, destructive remodeling of the extracellular matrix, and depletion of vascular smooth muscle cells. We hypothesized that genes involved in these events could harbor changes that make individuals more susceptible to developing aneurysms. This study identified significant genetic associations between DNA sequence changes in tissue inhibitor of metalloproteinase 1 (TIMP1), TIMP3, matrix metalloproteinase 10 (MMP10) and elastin (ELN) genes, and AAA. The results will require confirmation using an independent set of samples. After replication it is possible that these sequence changes in combination with other risk factors could be used in the future to identify individuals who are at increased risk for developing an AAA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944607      PMCID: PMC1249499          DOI: 10.1016/j.jvs.2005.02.020

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  39 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Identification of novel common polymorphisms in the promoter region of the TIMP-3 gene in Czech population.

Authors:  M Beránek; K Kanková; J Muzík
Journal:  Mol Cell Probes       Date:  2000-08       Impact factor: 2.365

3.  Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.

Authors:  D M Hovsepian; S J Ziporin; M K Sakurai; J K Lee; J A Curci; R W Thompson
Journal:  J Vasc Interv Radiol       Date:  2000 Nov-Dec       Impact factor: 3.464

4.  Primer-extension preamplified DNA is a reliable template for genotyping.

Authors:  Helena Kuivaniemi; Sungpil Yoon; Hidenori Shibamura; Magdalena Skunca; Sompong Vongpunsawad; Gerard Tromp
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

5.  Abdominal aortic aneurysm in women.

Authors:  F A Lederle; G R Johnson; S E Wilson
Journal:  J Vasc Surg       Date:  2001-07       Impact factor: 4.268

Review 6.  Familial abdominal aortic aneurysm: a systematic review of a genetic background.

Authors:  C J van Vlijmen-van Keulen; G Pals; J A Rauwerda
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-08       Impact factor: 7.069

7.  Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms.

Authors:  S Goodall; M Crowther; D M Hemingway; P R Bell; M M Thompson
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

8.  Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.

Authors:  E Petersen; A Gineitis; F Wågberg; K A Angquist
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-11       Impact factor: 7.069

9.  Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.

Authors:  S J Price; D R Greaves; H Watkins
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

10.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.

Authors:  R Pyo; J K Lee; J M Shipley; J A Curci; D Mao; S J Ziporin; T L Ennis; S D Shapiro; R M Senior; R W Thompson
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

View more
  24 in total

Review 1.  Aortic aneurysms: an immune disease with a strong genetic component.

Authors:  Helena Kuivaniemi; Chris D Platsoucas; M David Tilson
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

2.  Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin II.

Authors:  Ratnadeep Basu; Dong Fan; Vijay Kandalam; Jiwon Lee; Subhash K Das; Xiuhua Wang; Troy A Baldwin; Gavin Y Oudit; Zamaneh Kassiri
Journal:  J Biol Chem       Date:  2012-11-09       Impact factor: 5.157

3.  TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.

Authors:  Hsiu-Ting Tsai; Ming-Ju Hsieh; Hui-Ling Chiou; Hsiang-Lin Lee; Min-Chieh Hsin; Yi-Sheng Liou; Chen-Chieh Yang; Shun-Fa Yang; Wu-Hsien Kuo
Journal:  Tumour Biol       Date:  2014-06-07

Review 4.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

5.  Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta.

Authors:  Vaiva Lesauskaite; Giedre Sinkunaite-Marsalkiene; Abdonas Tamosiunas; Rimantas Benetis
Journal:  Eur J Cardiothorac Surg       Date:  2010-12-15       Impact factor: 4.191

6.  Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm.

Authors:  L Smallwood; R Allcock; F van Bockxmeer; N Warrington; L J Palmer; B Iacopetta; J Golledge; P E Norman
Journal:  Br J Surg       Date:  2008-10       Impact factor: 6.939

7.  Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Dietmar Krex; Eberhard Kuhlisch; Karl G Schmidt; Christian Pilarsky; Wolfgang Schneiders; Hans D Saeger; Hendrik Bergert
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

8.  Association of the TGF-beta receptor genes with abdominal aortic aneurysm.

Authors:  A F Baas; J Medic; R van 't Slot; C G de Kovel; A Zhernakova; R H Geelkerken; S E Kranendonk; S M van Sterkenburg; D E Grobbee; A P Boll; C Wijmenga; J D Blankensteijn; Y M Ruigrok
Journal:  Eur J Hum Genet       Date:  2009-08-12       Impact factor: 4.246

Review 9.  Engineering complex tissues.

Authors:  Antonios G Mikos; Susan W Herring; Pannee Ochareon; Jennifer Elisseeff; Helen H Lu; Rita Kandel; Frederick J Schoen; Mehmet Toner; David Mooney; Anthony Atala; Mark E Van Dyke; David Kaplan; Gordana Vunjak-Novakovic
Journal:  Tissue Eng       Date:  2006-12

10.  Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

Authors:  Leonardo Lorente; María M Martín; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Blanquer; Josune Orbe; José A Rodríguez; Alejandro Jiménez; Juan M Borreguero-León; Felipe Belmonte; Juan C Medina; Maria C Llimiñana; José M Ferrer-Agüero; José Ferreres; María L Mora; Santiago Lubillo; Manuel Sánchez; Ysamar Barrios; Antonio Sierra; José A Páramo
Journal:  Crit Care       Date:  2009-10-02       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.